Helicobacter pylori Infection. Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
Conditions
Interventions
Intervention 1: B group : cap placebo/ 1 cap / q 12 h and standard regimen for H. pylori eradication. Intervention 2: A group: cap Familact / 1 cap/ q 12 h and standard regimen for H. pylori eradicati
Placebo
Treatment - Drugs
B group : cap placebo/ 1 cap / q 12 h and standard regimen for H. pylori eradication
A group: cap Familact / 1 cap/ q 12 h and standard regimen for H. pylori eradication
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: inclusion criteria: Age >18 Years; Dyspepsia; confirmed H.Pylori Exclusion criteria : acute and chronic GI disease; Renal failure; Neurological disease; use of Antibiotic or probiotic within previous 30 days
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| H.pylori Infection. Timepoint: Before and 4 weeks after end of treatment. Method of measurement: Fecal H.pylori or Urea Breathing Test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Allergia; Diarrea; Nausea; Vometing; Bloating. Timepoint: Before and 4 weeks after end of treatment. Method of measurement: Hystory and Physical exam. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Bakhshipour, M.D
Zahedan University of Medical Sciences
Outcome results
None listed